Placebo-controlled clinical trial shows that non-invasive radiation therapy provides a conservative option compared to medications and joint surgery. A new randomized, placebo-controlled clinical tria ...

Innovative NBTXR3 shows promise in enhancing radiotherapy for recurrent head and neck cancer, potentially transforming ...

The national clinical trial explores whether chemo and radiation are effective treatments for early-stage breast cancer ...

Some of the most commonly used medications for osteoporosis can lead to osteonecrosis of the jaw (ONJ), a rare but serious ...

Patients with advanced cancer gained nearly a full year of additional life if they quit smoking, compared to those who kept ...

The phase 2 EXTEND trial tested the progression-free survival (PFS) benefits of metastasis-directed therapy by solid tumor type.

Several studies highlighted at a recent meeting document the growing toll prior authorization takes on patients and physicians.

“It is never too late, and no one is ever ‘too sick’ to quit smoking,” said senior researcher Dr. Li-Shiun Chen, director of ...

Giving up smoking may have benefits even to those with the most advanced stages of cancer, new research suggests. Published in the Journal of the National Comprehensive Cancer Network, the study found ...

Recurrent prostate cancer patients with luminal B tumors may benefit from hormone therapy added to radiation following surgery.

The development could help scientists develop patient-specific treatments and one day offer a lab-grown lung transplant option.

CEL-SCI Corporation (NYSE American: CVM), a clinical stage cancer immunotherapy company, today announced that Geert Kersten, Chief Executive Officer, is scheduled to present at the LD Micro "Main ...